secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001213900-25-022237
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Citius shareholders defeat share-increase proposal, elect all director nominees
-------------------------------------------------------------------------------

- Proposal to raise authorized shares from 26M to 260M failed with 3,222,490 for vs. 1,934,414 against.
- All seven director nominees elected; Leonard Mazur received 2,301,986 for, 983,591 withheld.
- Advisory vote on executive compensation approved: 1,943,011 for, 1,196,649 against, 1,969,380 broker non-votes.
- Ratification of Wolf & Co. as auditor for FY2025 passed with 4,466,905 for, 592,161 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025022237/0001213900-25-022237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025022237/ea0233790-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-022237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer